Quantum Biopharma (QNTM) Short Interest Ratio & Short Volume

Short interest is the volume of Quantum Biopharma shares that have been sold short but have not yet been closed out or covered. As of September 30th, traders have sold 82,500 shares of QNTM short. Learn More on Quantum Biopharma's current short interest.

Quantum Biopharma saw a increase in short interest in the month of September. As of September 30th, there was short interest totaling 82,500 shares, an increase of 33.5% from the previous total of 61,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Quantum Biopharma: Zura Bio Limited (5.00%), MediWound Ltd. (10.89%), Pyxis Oncology, Inc. (9.36%), Protara Therapeutics, Inc. (6.38%), GENFIT S.A. Unsponsored ADR (0.06%), Rani Therapeutics Holdings, Inc. (0.41%), Eupraxia Pharmaceuticals Inc. (0.77%), Coherus Oncology, Inc. (26.79%), Cassava Sciences, Inc. (15.38%), Eledon Pharmaceuticals, Inc. (11.17%),

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Corporation ($15.71 billion), Robinhood Markets, Inc. ($7.56 billion), Reddit Inc. ($4.55 billion), Coinbase Global, Inc. ($4.53 billion), CoreWeave Inc. ($4.43 billion), Charter Communications, Inc. ($4.07 billion), Seagate Technology Holdings PLC ($3.94 billion), IonQ, Inc. ($3.78 billion), TC Energy Corporation ($3.13 billion), and Live Nation Entertainment, Inc. ($3.12 billion). View all of the most shorted stocks.

Short selling QNTM is an investing strategy that aims to generate trading profit from Quantum Biopharma as its price is falling. QNTM shares are trading down $0.54 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Quantum Biopharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of QNTM, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including QNTM, twice per month. The most recent reporting period available is September, 30 2025.